Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Zinc helps reduce the severity of depression.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Topical minoxidil does not change the activity of hair follicle enzymes that metabolize it.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.